Pharming Group NV
F:PHGN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pharming Group NV
F:PHGN
|
NL |
|
Lovisa Holdings Ltd
F:LO7
|
AU |
|
E
|
Euro Sun Mining Inc
OTC:CPNFF
|
CA |
|
C
|
Cheniere Energy Inc
XMUN:CHQ1
|
US |
|
F
|
First Horizon Corp
F:FT2
|
US |
|
L
|
L3harris Technologies Inc
F:HRS
|
US |
|
L
|
L3harris Technologies Inc
DUS:HRS
|
US |
|
Indika Energy Tbk PT
F:I41
|
ID |
|
Vivoryon Therapeutics NV
AEX:VVY
|
DE |
|
H
|
Hang Seng Bank Ltd
XBER:HSB
|
HK |
|
Collins Foods Ltd
ASX:CKF
|
AU |
|
K
|
Keppel Corporation Ltd
DUS:KEP1
|
SG |
|
Praemium Ltd
ASX:PPS
|
AU |
|
M K Proteins Ltd
NSE:MKPL
|
IN |
|
China Petroleum & Chemical Corp
OTC:SNPMF
|
CN |
Wall St Price Targets
PHGN Price Targets Summary
Pharming Group NV
According to Wall Street analysts, the average 1-year price target for PHGN is 2.226 EUR with a low forecast of 1.793 EUR and a high forecast of 2.693 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PHGN's stock price target?
Price Target
2.226
EUR
According to Wall Street analysts, the average 1-year price target for PHGN is 2.226 EUR with a low forecast of 1.793 EUR and a high forecast of 2.693 EUR.
What is the Revenue forecast for Pharming Group NV?
Projected CAGR
17%
Over the last 14 years, the compound annual growth rate for Revenue has been 41%. The projected CAGR for the next 5 years is 17%.
What is the Operating Income forecast for Pharming Group NV?
Projected CAGR
35%
The compound annual growth rate for Operating Income over the next 5 years is 35%.
What is the Net Income forecast for Pharming Group NV?
Projected CAGR
130%
The compound annual growth rate for Net Income over the next 4 years is 130%.
